JohnsonSRMcChesneyCBeanJA. Epidemiology of premenstrual symptoms in a nonclinical sample. J Reprod Med1988;33:340–6.
2.
SteinerM.Premenstrual syndrome and premenstrual dysphoric disorder: Guidelines for management. J Psychiatr Neurosci2000;25:459–68.
3.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.Washington (DC): American Psychiatric Association; 1994. p 715–8.
4.
BlochMSchmidtPJRubinowDR. Premenstrual syndrome: Evidence for symptom stability across cycles. Am J Psychiatry1997;154:1741–6.
5.
PearlsteinTBHalbreichUBatzarEDBrownCSEndicottJFrankE, and others. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry2000;61:101–9.
6.
YonkersKAHalbreichUFreemanEBrownCEndicottJFrankE, and others. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: A randomized controlled study. JAMA1997;278:983–8.
LeonACOlfsonMPorteraLFaberLSheehanDV. Assessing psychiatric impairment in primary care with the Sheehan disability scale. Int J Psychiatry Med1997;27(2):93–105.
10.
EndicottJNeeJHarrisonWBlumenthalR.Quality of life enjoyment and satisfaction questionnaire: A new measure. Psychopharmacol Bull1993;29:321–6.